Gianluca Bossi
Via Elio Chianesi, 53 00144
Rome, 00144, Italy
Rome, 00144, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Repurposed AT9283 triggers anti-tumoral effects by targeting MKK3 oncogenic functions in Colorectal Cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 22, 2024
Activated MKK3/MYC crosstalk impairs dabrafenib response in BRAFV600E colorectal cancer leading to resistance.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 18, 2023
Dissection of the MKK3 Functions in Human Cancer: A Double-Edged Sword?
Journal: Cancers
Published: November 26, 2021
SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 05, 2021
TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 04, 2020
p38β (MAPK11) mediates gemcitabine-associated radiosensitivity in sarcoma experimental models.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: April 06, 2020
The p38 MAPK Signaling Activation in Colorectal Cancer upon Therapeutic Treatments.
Journal: International journal of molecular sciences
Published: March 13, 2020
Approaching the challenges of MKK3/p38delta MAPK targeting for therapeutic purpose in colorectal cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 03, 2019
Che-1/AATF binds to RNA polymerase I machinery and sustains ribosomal RNA gene transcription.
Journal: Nucleic acids research
Published: July 24, 2019
Last Updated: 09/26/2026